Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.
Business & Industry
- Amgen contributes $2 million to groundbreaking program providing cancer patients of all backgrounds access to U.S. clinical trials
- AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
- FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer
- GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
- Pfizer reaches a global agreement with AbbVie
Research & Development
- Helping the anti-parasitic medicine go down
- Scientists pave the way for saliva test for Alzheimer's disease
- Drug cocktail turns off the juice to cancer cells
- MIT engineers repurpose wasp venom as an antibiotic drug
- Statins overprescribed for primary prevention
- Cannabis-based compound may reduce seizures in children with epilepsy
- New Parkinson's disease drug target revealed through study of fatty acids
Conferences & Events
- 21st Annual Superbugs & Superdrugs Conference
- SMi Group announces the 10th Annual RNA Therapeutics Conference
- Pre-Filled Syringes & Injectable Drug Devices Europe 2018
- Social Media in the Pharmaceutical Industry Conference 2019
- Lyophilization USA Conference 2018
- SMi presents the 13th annual industry leading conference: Cold Chain Distribution
- Orphan Drugs and Rare Diseases Conference 2018
Regulatory Affairs
- FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
- FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
- FDA approves new treatment for patients with acute myeloid leukemia
- FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
- FDA highlights record-breaking number of generic drug approvals in October